ACHV stock: buy or sell?
September 20th, 2019
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients.
Should I buy ACHV stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Achieve Life Sciences stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Achieve Life Sciences stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we detected 4 ratings published for ACHV stock in the last 30 days. The general sentiment of these ratings is bullish for ACHV stock, with 4 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-9||LADENBURG THALM/SH SH||n/a||Buy|
|2019-6-11||LADENBURG THALM/SH SH||Positive||Buy|
ACHV stock analysis
Achieve Life Sciences shares boosted 6.16% to $2.24 today.
Shares of Achieve Life Sciences closed today at $2.24 and boosted a dazzling 6.16%. From a daily outlook perspective, ACHV is drawing an uptrend of rising tops and rising bottoms. Since its last top on Sep/10 at $2.51, price slid and found support around $2.07. Breaking down under $2.07 would cancel the current uptrend and it might slide further to test lower supports. Note that $2.51 might act as a resistance line. Trading the long side, we should wait to a new breakout over $2.51 to find the next buy point. Since SMA100d and SMA200d crossed up on May, ACHV price slid a -45.76%.
Achieve Life Sciences ended this week at $2.24 and declined an unpleasant -0.88%. Early September ACHV boosted an astounding 13.48% in just one week.
The downtrend marked by ACHV has left successive falling tops and bottoms. If the support holds the price, this might mark a double bottom configuration and create a flat-base to reverse this downtrend. Since mid June, when ACHV stock price broke down the 40-weeks moving avarage line, it slid $-1.42 per share (-38.80%). Stocks under the 40w moving average line are usually not recommended for average traders. Since late April when SMA20w and SMA40w crossed up, ACHV price slipped $-2.11 per share (-48.51%).
ACHV stock price history
ACHV IPO was on October 13th, 2000 at $1,670.63 per share1. Since then, ACHV stock declined a -99.90%, with a yearly average of -5.60%.
1: Adjusted price after possible price splits or reverse-splits.
ACHV stock historical price chart
ACHV stock reached 52-week highs on September at $5.25, and all-time highs 2005-10-18 with a price of 9979.2.
ACHV stock price target is $13.00How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We have 4 price targets for ACHV stock posted in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-9||LADENBURG THALM/SH SH||Reiterates||n/a||$20.00||-|
|2019-6-11||LADENBURG THALM/SH SH||Reiterates||$12.00||$20.00||66.7%|
Financials and fundamental analysis
Earnings date and Earnings per ShareSince last March, when Achieve Life Sciences published its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2015, last anual turnover report draw a dreadful slide of -72.13% to $5.06 million USD. When comparing 2016 vs 2015, in line, profit margin (that is, the net income divided by revenues) collapsed a -305.13% to -397.65%.
|2013||$30 M||-||$-31.85 M-106.6%||-|
|2014||$27 M||-9.25%||$-26.24 M-96.8%||-17.61%|
|2015||$18 M||-33.03%||$-16.80 M-92.5%||-35.97%|
|2016||$5.06 M||-72.13%||$-20.13 M-397.6%||19.81%|
Quarterly financial resultsReported quarter income marked $-3.64 million with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Achieve Life Sciences sales marked a neutral move and remained stable a nan%. Looking back to recent quarterly results, Achieve Life Sciences posted 7 negative quarters in a row.
Achieve Life Sciences ownershipWhen you are planning to invest in shares of a stock, it's always worth to have a look its ownership structure.
Achieve Life Sciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 4.97% of all shares.
In case of Achieve Life Sciences stock, 28.42% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ACHV stock account 0.00%, no big difference from last month.
For a better understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$18.1 M|
|Total shares||8.1 M|
|Float shares||7.2 M|
|- Institutional holdings (%)||28.4%|
|- Insider holdings (%)||5.0%|
|Shares in short selling||0.0%|
|Friday, September 20th, 2019|
|Day range||$2.05 - $2.29|
|Average true range||$0.18|
|50d mov avg||$1.97|
|100d mov avg||$2.58|
|200d mov avg||$2.42|
Achieve Life Sciences performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Achieve Life Sciences, the comparison is made against .
|ACHVAchieve Life Scie...||-3.45%||-20.85%||-10.04%|